Literature DB >> 6323528

Circulating DNA in systemic lupus erythematosus. Isolation and characterization.

C R Steinman.   

Abstract

Immunoprecipitable double-stranded (dsDNA) was previously shown to persist in the circulation of a clinically recognizable subgroup of patients with systemic lupus erythematosus (SLE). Plasma from 10 such patients was subjected to a DNA isolation procedure that used a combination of proteolysis, phenol extraction, and hydroxylapatite adsorption and elution in the presence of urea. The isolated dsDNA was radiolabeled by nick translation and then characterized by isopyknic ultracentrifugation in CsCl under both neutral and alkaline conditions, as well as after digestion with S1-endonuclease. These experiments demonstrated essential identity in nucleotide base composition between the plasma-derived DNA and human genomic DNA. The presence of specific human base sequences in the plasma DNA was demonstrated by finding that authentic human genomic DNA accelerated the renaturation of plasma DNA when compared with the effect of nonhuman, control DNA. The proportion of such sequences in plasma DNA was estimated by attempting to renature the plasma DNA in the presence of human DNA under conditions shown to result in complete renaturation of human DNA in model experiments. In this way, a minimum of 47% of plasma DNA base sequences could be shown also to be present in human genomic DNA. However, an average of 10-20% of the plasma-derived DNA failed to renature under these conditions, a result that was further confirmed by comparing the renaturation of the tritium-labeled plasma DNA specimens, in double-label experiments, with internal controls consisting of 14C-labeled authentic human DNA. Attempts to drive the reaction to completion with human DNA led to a similar conclusion. The relative nonrenaturability of this fraction of plasma DNA did not appear to be attributable to extensive chain breakage, although adequate analysis of this DNA subfraction was limited by reagent availability. It was therefore concluded that, in this group of SLE patients, persistently circulating DNA consisted largely of base sequences also found in human genomic DNA. The additional presence in plasma of a DNA subfraction that differed in its renaturation behavior from human genomic DNA was recognized, although its significance could not be established with certainty.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6323528      PMCID: PMC425087          DOI: 10.1172/JCI111278

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Uptake and release of DNA by lymphoid tissue and cells.

Authors:  I Olsen; G Harris
Journal:  Immunology       Date:  1974-12       Impact factor: 7.397

2.  Excretion of deoxyribonucleic acid by lymphocytes stimulated with phytohemagglutinin or antigen.

Authors:  J C Rogers; D Boldt; S Kornfeld; A Skinner; C R Valeri
Journal:  Proc Natl Acad Sci U S A       Date:  1972-07       Impact factor: 11.205

3.  Analysis of repeating DNA sequences by reassociation.

Authors:  R J Britten; D E Graham; B R Neufeld
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

4.  Detection of circulating DNA by counterimmunoelectrophoresis (CIE).

Authors:  G L Davis; J S Davis
Journal:  Arthritis Rheum       Date:  1973 Jan-Feb

5.  The release of DNA into serum and synovial fluid.

Authors:  G R Hughes; S A Cohen; R W Lightfoot; J I Meltzer; C L Christian
Journal:  Arthritis Rheum       Date:  1971 Mar-Apr

6.  Nucleic acid concentrations in normal human plasma.

Authors:  R C Kamm; A G Smith
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  [Study of several indices of nuclein metabolism in patients with arteriosclerosis].

Authors:  V P Kaznacheev; Ia V Poliakov
Journal:  Kardiologiia       Date:  1967-07       Impact factor: 0.395

8.  Association between polyarteritis and Australia antigen.

Authors:  D J Gocke; K Hsu; C Morgan; S Bombardieri; M Lockshin; C L Christian
Journal:  Lancet       Date:  1970-12-05       Impact factor: 79.321

9.  Use of nucleic acid hybridization for specific detection of submicrogram quantities of DNA, and its application to human plasma.

Authors:  C R Steinman
Journal:  Clin Chem       Date:  1975-03       Impact factor: 8.327

10.  DNA:anti-DNA complexes: their detection in systemic lupus erythematosus sera.

Authors:  R J Harbeck; E J Bardana; P F Kohler; R I Carr
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

View more
  20 in total

1.  The effect of dexamethasone on the generation of plasma DNA from dead and dying cells.

Authors:  Ning Jiang; David S Pisetsky
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

Review 2.  Defects in the disposal of dying cells lead to autoimmunity.

Authors:  Udo S Gaipl; Sandra Franz; Reinhard E Voll; Ahmed Sheriff; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

Review 3.  Apoptosis and autoimmunity: when apoptotic cells break their silence.

Authors:  Sandra Franz; Udo S Gaipl; Luis E Munoz; Ahmed Sheriff; Alexandra Beer; Joachim R Kalden; Martin Herrmann
Journal:  Curr Rheumatol Rep       Date:  2006-08       Impact factor: 4.592

Review 4.  Liquid biopsy in early stage lung cancer.

Authors:  Cristina Pérez-Ramírez; Marisa Cañadas-Garre; Ana I Robles; Miguel Ángel Molina; María José Faus-Dáder; Miguel Ángel Calleja-Hernández
Journal:  Transl Lung Cancer Res       Date:  2016-10

Review 5.  Regulation of interleukin-10 gene expression in macrophages engulfing apoptotic cells.

Authors:  Yan Zhang; Ha-Jeong Kim; Soichiro Yamamoto; Xiaoyan Kang; Xiaojing Ma
Journal:  J Interferon Cytokine Res       Date:  2010-03       Impact factor: 2.607

Review 6.  Antibodies to DNA in patients with systemic lupus erythematosus. Their role in the diagnosis, the follow-up and the pathogenesis of the disease.

Authors:  R Smeenk; K Brinkman; H van den Brink; R M Termaat; J Berden; H Nossent; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

Review 7.  Targeting Toll-like receptors for treatment of SLE.

Authors:  Christopher G Horton; Zi-jian Pan; A Darise Farris
Journal:  Mediators Inflamm       Date:  2010-09-19       Impact factor: 4.711

8.  Endogenous circulating DNA in systemic lupus erythematosus. Occurrence as multimeric complexes bound to histone.

Authors:  P M Rumore; C R Steinman
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

Review 9.  Pathogenesis of SLE: immunopathology in man.

Authors:  J R Kalden; T H Winkler; M Herrmann; F Krapf
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 10.  CpG DNA: a pathogenic factor in systemic lupus erythematosus?

Authors:  A M Krieg
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.